At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
SDGR Schrodinger Inc.
Market Closed 11-22 16:00:00 EST
20.84
+0.47
+2.31%
盘后21.10
+0.26+1.25%
19:57 EST
High21.21
Low20.08
Vol623.51K
Open20.48
D1 Closing20.37
Amplitude5.57%
Mkt Cap1.52B
Tradable Cap1.22B
Total Shares72.86M
T/O12.98M
T/O Rate1.07%
Tradable Shares58.48M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Schrödinger: Positive Signs Despite The Share Price Decline
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.